At the heart of this evolution lies the growing prominence of biologics contract manufacturing, a strategic partnership that is reshaping the way pharmaceutical companies approach their production ...

Ferring Pharmaceutical officially opened its new 12,000-square-foot gene therapy manufacturing facility located within its US ...

LOTTE BIOLOGICS has signed a contract manufacturing agreement for antibody therapeutics with Ottimo Pharma, a biopharmaceutical company developing first-in-class, PD1/VEGFR2 dual pathway antibodies to ...

LONDON, Jan. 15, 2024 /PRNewswire/ -- The global pharmaceutical contract manufacturing market is anticipated to be worth USD 90 billion in 2023 and is expected to reach USD 140 billion by 2030.

Dublin, March 19, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Small Molecule, Biologics), Drug, Service, Scale of ...

Fill Finish Fill Finish Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of ...

How can we properly prepare for reshoring while ensuring we're building tomorrow's manufacturing infrastructure today?

The duo believe that contract packaging organizations ... actions such as designing reusable autoinjectors and manufacturing ...